Delivery Order SPE2DB22D2206-SPE2DB25FEA17

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEA17
    Delivery Order

This federal contract award, valued at $42,692.47, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FEA17) under an Indefinite Delivery Contract (SPE2DB22D2206) and covers the procurement of BIKTARVY 50-200-25 MG TABLET, a specialty medication. The contract has a firm fixed-price pricing type and an ultimate completion date of October 31, 2024. There is no set-aside designation mentioned for this award. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 1/29/25, 9:26 AM